| abstract |
The present invention relates to certain purine nucleoside analogs containing a carbocyclic ring in place in the sugar residue, to the salts, esters and pharmaceutically acceptable derivatives thereof, to their methods of preparation, to the pharmaceutical formulations containing them and to the use of these compounds in therapy, in particular in the treatment or propylaxis of certain viral infections. |